Estrogens as potential therapeutic agents in multiple sclerosis

Central Nervous System Agents in Medicinal Chemistry

Volumn 9, Issue 2, 2009, Pages 87-94

  Niino, Masaaki ^a   Hirotani, Makoto ^a   Fukazawa, Toshiyuki ^b   Kikuchi, Seiji ^b   Sasaki, Hidenao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO MEDICAL CENTER   (Japan)

Author keywords

Cytokines; Estrogen; Estrogen receptor; Experimental autoimmune encephalomyelitis; Genetics; Inflammation; Multiple sclerosis

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; DIPROPIONITRILE; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; ESTRONE; ETHINYLESTRADIOL; RALOXIFENE; UNCLASSIFIED DRUG; WAY 138923; WAY 202041;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; BRAIN ATROPHY; CLINICAL TRIAL; DISEASE ACTIVITY; DRUG MEGADOSE; ESTROGEN ACTIVITY; ESTROGEN THERAPY; GENETIC POLYMORPHISM; HORMONE BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESTROGENS; FEMALE; FLOW CYTOMETRY; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OVARIECTOMY; TH1 CELLS;

EID: 67049142934     PISSN: 18715249     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152409788452054     Document Type: Review

References (83)

1. Whitacre, C.C. Sex differences in autoimmune disease. Nat. Immunol., 2001, 2(9), 777-780. (Pubitemid 34906434)
2. Birk, K.; Ford, C.; Smeltzer, S.; Ryan, D.; Miller, R.; Rudick, R.A. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch. Neurol., 1990, 47(7), 738-742. (Pubitemid 20208612)
3. Bebo, B.F. Jr.; Vandenbark, A.A.; Offner, H. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J. Neurosci. Res., 1996, 45(6), 680-689. (Pubitemid 26332555)
4. Coelingh Bennink, H.J. Are all estrogens the same? Maturitas, 2004, 47(4), 269-275. (Pubitemid 38520113)
5. Nilsson, S.; Mäkelä, S.; Treuter, E.; Tujague, M.; Thomsen, J.; Andersson, G.; Enmark, E.; Pettersson, K.; Warner, M.; Gustafsson, J.A. Mechanisms of estrogen action. Physiol. Rev., 2001, 81(4), 1535-1565.
6. Czlonkowska, A.; Ciesielska, A.; Gromadzka, G.; Kurkowska-Jastrzebska, I. Estrogen and cytokines production - the possible cause of gender differences in neurological diseases. Curr. Pharm. Des., 2005, 11(8), 1017-1030. (Pubitemid 40331302)
7. Stimson, W.H. Oestrogen and human T lymphocytes: presence of specific receptors in the T-suppressor/cytotoxic subset. Scand. J. Immunol., 1988, 28(3), 345-350. (Pubitemid 18263222)
8. Smithson, G.; Medina, K.; Ponting, I.; Kincade, P.W. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J. Immunol., 1995, 155(7), 3409-3417.
9. Thurmond, T.S.; Murante, F.G.; Staples, J.E.; Silverstone, A.E.; Korach, K.S.; Gasiewicz, T.A. Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology, 2000, 141(7), 2309-2318. (Pubitemid 32269049)
10. Kawashima, I.; Seiki, K.; Sakabe, K.; Ihara, S.; Akatsuka, A.; Katsumata, Y. Localization of estrogen receptors and estrogen receptor-mRNA in female mouse thymus. Thymus, 1992, 20(2), 115-121.
11. Bellido, T.; Girasole, G.; Passeri, G.; Yu, X.P.; Mocharla, H.; Jilka, R.L.; Notides, A.; Manolagas, S.C. Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: upregulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3. Endocrinology, 1993, 133(2), 553-562. (Pubitemid 23238863)
12. Onoe, Y.; Miyaura, C.; Ohta, H.; Nozawa, S.; Suda, T. Expression of estrogen receptor beta in rat bone. Endocrinology, 1997, 138(10), 4509-4512. (Pubitemid 27408505)
13. Mosselman, S.; Polman, J.; Dijkema, R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett., 1996, 392(1), 49-53. (Pubitemid 26268330)
14. Phiel, K.L.; Henderson, R.A.; Adelman, S.J.; Elloso, M.M. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol. Lett., 2005, 97(1), 107-113. (Pubitemid 40038861)
15. Smithson, G.; Couse, J.F.; Lubahn, D.B.; Korach, K.S.; Kincade, P.W. The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J. Immunol., 1998, 161(1), 27-34. (Pubitemid 28285502)
16. Medina, K.L.; Smithson, G.; Kincade, P.W. Suppression of B lymphopoiesis during normal pregnancy. J. Exp. Med., 1993, 178(5), 1507-1515. (Pubitemid 2003065)
17. Gilmore, W.; Weiner, L.P.; Correale, J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol., 1997, 158(1), 446-451. (Pubitemid 127483887)
18. Maoz, H.; Kaiser, N.; Halimi, M.; Barak, V.; Haimovitz, A.; Weinstein, D.; Simon, A.; Yagel, S.; Biran, S.; Treves, A.J. The effect of estradiol on human myelomonocytic cells. 1. Enhancement of colony formation. J. Reprod. Immunol., 1985, 7(4), 325-335. (Pubitemid 15040038)
19. Boorman, G.A.; Luster, M.I.; Dean, J.H.; Wilson, R.E. The effect of adult exposure to diethylstilbestrol in the mouse on macrophage function and numbers. J. Reticuloendothel. Soc., 1980, 28(6), 547-560. (Pubitemid 11221126)
20. Nilsson, N.; Carlsten, H. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation. Cell Immunol., 1994, 158(1), 131-139. (Pubitemid 24321638)
21. Cid, M.C.; Kleinman, H.K.; Grant, D.S.; Schnaper, H.W.; Fauci, A.S.; Hoffman, G.S. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J. Clin. Invest., 1994, 93(1), 17-25. (Pubitemid 24983180)
22. Rubanyi, G.M.; Freay, A.D.; Kauser, K.; Sukovich, D.; Burton, G.; Lubahn, D.B.; Couse, J.F.; Curtis, S.W.; Korach, K.S. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J. Clin. Invest., 1997, 99(10), 2429-2437. (Pubitemid 27227721)
23. Maret, A.; Coudert, J.D.; Garidou, L.; Foucras, G.; Gourdy, P.; Krust, A.; Dupont, S.; Chambon, P.; Druet, P.; Bayard, F.; Guéry, J.C. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur. J. Immunol., 2003, 33(2), 512-521. (Pubitemid 36267617)
24. + T cells and macrophages into the CNS of mice developing experimental encephalomyelitis. Clin. Immunol., 2002, 102(3), 275-282.
25. Offner, H. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. J. Neurosci. Res., 2004, 78(5), 603-624. (Pubitemid 39657579)
26. Janis, K.; Hoeltke, J.; Nazareth, M.; Fanti, P.; Poppenberg, K.; Aronica, S.M. Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes. Am. J. Reprod. Immunol., 2004, 51(1), 22-31. (Pubitemid 38190328)
27. Baker, A.E.; Brautigam, V.M.; Watters, J.J. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor β. Endocrinology, 2004, 145(11), 5021-5032. (Pubitemid 39551121)
28. Drew, P.D.; Chavis, J.A. Female sex steroids: effects upon microglial cell activation. J. Neuroimmunol., 2000, 111(1-2), 77-85.
29. Vegeto, E.; Bonincontro, C.; Pollio, G.; Sala, A.; Viappiani, S.; Nardi, F.; Brusadelli, A.; Viviani, B.; Ciana, P.; Maggi, A. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci., 2001, 21(6), 1809-1818. (Pubitemid 32221364)
30. Morales, L.B.; Loo, K.K.; Liu, H.B.; Peterson, C.; Tiwari-Woodruff, S.; Voskuhl, R.R. Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J. Neurosci., 2006, 26(25), 6823-6833. (Pubitemid 44315243)
31. Garcia-Segura, L.M.; Azcoitia, I.; DonCarlos, L.L. Neuroprotection by estradiol. Prog. Neurobiol., 2001, 63(1), 29-60.
32. Perez-Polo, J.R.; Hall, K.; Livingston, K.; Westlund, K. Steroid induction of nerve growth factor synthesis in cell culture. Life Sci., 1977, 21(10), 1535-1544. (Pubitemid 9014399)
33. Cardona-Gómez, G.P.; Chowen, J.A.; Garcia-Segura, L.M. Estradiol and progesterone regulate the expression of insulin-like growth factor-I receptor and insulin-like growth factor binding protein-2 in the hypothalamus of adult female rats. J. Neurobiol., 2000, 43(3), 269-281. (Pubitemid 30350627)
34. Bimonte-Nelson, H.A.; Nelson, M.E.; Granholm, A.C. Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain. Neuroreport, 2004, 15(17), 2659-2663. (Pubitemid 40053958)
35. Toran-Allerand, C.D.; Singh, M.; Sétáló, G. Jr. Novel mechanisms of estrogen action in the brain: new players in an old story. Front. Neuroendocrinol., 1999, 20(2), 97-121. (Pubitemid 29215043)
36. Sohrabji, F.; Lewis, D.K. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front. Neuroendocrinol., 2006, 27(4), 404-414. (Pubitemid 44738016)
37. Takao, T.; Flint, N.; Lee, L.; Ying, X.; Merrill, J.; Chandross, K.J. 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J. Neurochem., 2004, 89(3), 660-673. (Pubitemid 38534152)
38. Evron, S.; Brenner, T.; Abramsky, O. Suppressive effect of pregnancy on the development of experimental allergic encephalomyelitis in rabbits. Am. J. Reprod. Immunol., 1984, 5(3), 109-113. (Pubitemid 14105804)
39. Mertin, L.A.; Rumjanek, V.M. Pregnancy and the susceptibility of Lewis rats to experimental allergic encephalomyelitis. J. Neurol. Sci., 1985, 68(1), 15-24. (Pubitemid 15075624)
40. Arnason, B.G.; Richman, D.P. Effect of oral contraceptives on experimental demyelinating disease. Arch. Neurol., 1969, 21(1), 103-108.
41. Trooster, W.J.; Teelken, A.W.; Kampinga, J.; Loof, J.G.; Nieuwenhuis, P.; Minderhoud, J.M. Suppression of acute experimental allergic encephalomyelitis by the synthetic sex hormone 17-alpha-ethinylestradiol: an immunological study in the Lewis rat. Int. Arch. Allergy Immunol., 1993, 102(2), 133-140. (Pubitemid 23285368)
42. Jansson, L.; Olsson, T.; Holmdahl, R. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J. Neuroimmunol., 1994, 53(2), 203-207. (Pubitemid 24272011)
43. Matejuk, A.; Adlard, K.; Zamora, A.; Silverman, M.; Vandenbark, A.A.; Offner, H. 17β-Estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J. Neurosci. Res., 2001, 65(6), 529-542. (Pubitemid 32847146)
44. Ito, A.; Bebo, B.F. Jr.; Matejuk, A.; Zamora, A.; Silverman, M.; Fyfe-Johnson, A.; Offner, H. Estrogen treatment down-regulates TNF-α production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol., 2001, 167(1), 542-552. (Pubitemid 32567822)
45. Matejuk, A.; Dwyer, J.; Hopke, C.; Vandenbark, A.A.; Offner, H. 17β-estradiol treatment profoundly down-regulates gene expression in spinal cord tissue in mice protected from experimental autoimmune encephalomyelitis. Arch. Immunol. Ther. Exp., 2003, 51(3), 185-193. (Pubitemid 36828181)
46. Matejuk, A.; Dwyer, J.; Zamora, A.; Vandenbark, A.A.; Offner, H. Evaluation of the effects of 17β-estradiol (17β-E2) on gene expression in experimental autoimmune encephalomyelitis using DNA microarray. Endocrinology, 2002, 143(1), 313-319. (Pubitemid 34056433)
47. Polanczyk, M.J.; Hopke, C.; Huan, J.; Vandenbark, A.A.; Offner, H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J. Neuroimmunol., 2005, 170(1-2), 85-92. (Pubitemid 41740909)
48. Offner, H.; Polanczyk, M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann. N.Y. Acad. Sci., 2006, 1089, 343-372. (Pubitemid 47092076)
49. Matejuk, A.; Bakke, A.C.; Hopke, C.; Dwyer, J.; Vandenbark, A.A.; Offner, H. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. J. Neurosci. Res., 2004, 77(1), 119-126. (Pubitemid 38850062)
50. Liu, H.Y.; Buenafe, A.C.; Matejuk, A.; Ito, A.; Zamora, A.; Dwyer, J.; Vandenbark, A.A.; Offner, H. Estrogen inhibition of EAE involves effects on dendritic cell function. J. Neurosci. Res., 2002, 70(2), 238-248.
51. Polanczyk, M.J.; Hopke, C.; Vandenbark, A.A.; Offner, H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res., 2006, 84(2), 370-378. (Pubitemid 44126289)
52. Matejuk, A.; Vandenbark, A.A.; Burrows, G.G.; Bebo, B.F. Jr.; Offner, H. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein. J. Immunol., 2000, 164(7), 3924-3931. (Pubitemid 30169853)
53. Subramanian, S.; Matejuk, A.; Zamora, A.; Vandenbark, A.A.; Offner, H. Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system. J. Immunol., 2003, 170(3), 1548-1555. (Pubitemid 36139527)
54. Kim, S.; Liva, S.M.; Dalal, M.A.; Verity, M.A.; Voskuhl, R.R. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology, 1999, 52(6), 1230-1238. (Pubitemid 29177927)
55. Palaszynski, K.M.; Liu, H.; Loo, K.K.; Voskuhl, R.R. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol., 2004, 149(1-2), 84-89. (Pubitemid 38352861)
56. Whitacre, C.C.; Reingold, S.C.; O'Looney, P.A. A gender gap in autoimmunity. Science, 1999, 283(5406), 1277-1278. (Pubitemid 129507205)
57. Bebo, B.F. Jr.; Fyfe-Johnson, A.; Adlard, K.; Beam, A.G.; Vandenbark, A.A.; Offner, H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol., 2001, 166(3), 2080-2089. (Pubitemid 32114698)
58. Barkhem, T.; Carlsson, B.; Nilsson, Y.; Enmark, E.; Gustafsson, J.; Nilsson, S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol. Pharmacol., 1998, 54(1), 105. (Pubitemid 28337592)
59. Liu, H.B.; Loo, K.K.; Palaszynski, K.; Ashouri, J.; Lubahn, D.B.; Voskuhl, R.R. Estrogen receptor α mediates estrogen's immune protection in autoimmune disease. J. Immunol., 2003, 171(12), 6936-6940. (Pubitemid 37532130)
60. Polanczyk, M.; Zamora, A.; Subramanian, S.; Matejuk, A.; Hess, D.L.; Blankenhorn, E.P.; Teuscher, C.; Vandenbark, A.A.; Offner, H. The protective effect of 17β-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-α. Am. J. Pathol., 2003, 163(4), 1599-1605. (Pubitemid 37175106)
61. Vegeto, E.; Belcredito, S.; Etteri, S.; Ghisletti, S.; Brusadelli, A.; Meda, C.; Krust, A.; Dupont, S.; Ciana, P.; Chambon, P.; Maggi, A. Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol. Proc. Natl. Acad. Sci. USA, 2003, 100(16), 9614-9619. (Pubitemid 37033976)
62. Garidou, L.; Laffont, S.; Douin-Echinard, V.; Coureau, C.; Krust, A.; Chambon, P.; Guéry, J.C. Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiolmediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol., 2004, 173(4), 2435-2442. (Pubitemid 39063100)
63. Merchenthaler, I.; Lane, M.V.; Numan, S.; Dellovade, T.L. Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses. J. Comp. Neurol., 2004, 473(2), 270-291. (Pubitemid 38569232)
64. Mitra, S.W.; Hoskin, E.; Yudkovitz, J.; Pear, L.; Wilkinson, H.A.; Hayashi, S.; Pfaff, D.W.; Ogawa, S.; Rohrer, S.P.; Schaeffer, J.M.; McEwen, B.S.; Alves, S.E. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology, 2003, 144(5), 2055-2067. (Pubitemid 36543346)
65. Harris, H.A.; Albert, L.M.; Leathurby, Y.; Malamas, M.S.; Mewshaw, R.E.; Miller, C.P.; Kharode, Y.P.; Marzolf, J.; Komm, B.S.; Winneker, R.C.; Frail, D.E.; Henderson, R.A.; Zhu, Y.; Keith, J.C. Jr. Evaluation of an estrogen receptor-β agonist in animal models of human disease. Endocrinology, 2003, 144(10), 4241-4249. (Pubitemid 37204818)
66. Mewshaw, R.E.; Edsall, R.J. Jr.; Yang, C.; Manas, E.S.; Xu, Z.B.; Henderson, R.A.; Keith, J.C. Jr.; Harris, H.A. ERβ ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERβ selectivity. J. Med. Chem., 2005, 48(12), 3953-3979. (Pubitemid 40800606)
67. Elloso, M.M.; Phiel, K.; Henderson, R.A.; Harris, H.A.; Adelman, S.J. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. J. Endocrinol., 2005, 185(2), 243-252. (Pubitemid 40691791)
68. Tiwari-Woodruff, S.; Morales, L.B.; Lee, R.; Voskuhl, R.R. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)α and ERβ ligand treatment. Proc. Natl. Acad. Sci. USA, 2007, 104(37), 14813-14818. (Pubitemid 350003225)
69. Polanczyk, M.; Yellayi, S.; Zamora, A.; Subramanian, S.; Tovey, M.; Vandenbark, A.A.; Offner, H.; Zachary, J.F.; Fillmore, P.D.; Blankenhorn, E.P.; Gustafsson, J.A.; Teuscher, C. Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice. Am. J. Pathol., 2004, 164(6), 1915-1924. (Pubitemid 38669341)
70. Offner, H.; Adlard, K.; Zamora, A.; Vandenbark, A.A. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J. Clin. Invest., 2000, 105(10), 1465-1472. (Pubitemid 30322412)
71. Zorgdrager, A.; De Keyser, J. Menstrually related worsening of symptoms in multiple sclerosis. J. Neurol. Sci., 1997, 149(1), 95-97. (Pubitemid 27196387)
72. Pozzilli, C.; Falaschi, P.; Mainero, C.; Martocchia, A.; D'Urso, R.; Proietti, A.; Frontoni, M.; Bastianello, S.; Filippi, M. MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns. Neurology, 1999, 53(3), 622-624. (Pubitemid 29382062)
73. Smith, R.; Studd, J.W. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J. R. Soc. Med., 1992, 85(10), 612-613.
74. Sicotte, N.L.; Liva, S.M.; Klutch, R.; Pfeiffer, P.; Bouvier, S.; Odesa, S.; Wu, T.C.; Voskuhl, R.R. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol., 2002, 52(4), 421-428.
75. Soldan, S.S.; Alvarez Retuerto, A.I.; Sicotte, N.L.; Voskuhl, R.R. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol., 2003, 171(11), 6267-6274. (Pubitemid 37467250)
76. Liu, X.; Steffensen, K.R.; Sanna, A.; Arru, G.; Fois, M.L.; Rosati, G.; Sotgiu, S.; Link, H.; Gustafsson, J.A.; Huang, Y.M. Antiinflammatory nuclear receptor superfamily in multiple sclerosis patients from Sardinia and Sweden. Neurobiol. Dis., 2005, 20(3), 961-968. (Pubitemid 41622215)
77. Gennari, L.; Merlotti, D.; De Paola, V.; Calabrò, A.; Becherini, L.; Martini, G.; Nuti, R. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am. J. Epidemiol., 2005, 161(4), 307-320 (Pubitemid 40256202)
78. Niino, M.; Kikuchi, S.; Fukazawa, T.; Yabe, I.; Tashiro, K. Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis. J. Neurol. Sci., 2000, 179(1-2), 70-75.
79. Tajouri, L.; Fernandez, F.; Tajouri, S.; Detriche, G.; Szvetko, A.; Colson, N.; Csurhes, P.; Pender, M.P.; Griffiths, L.R. Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population. J. Neurol. Sci., 2007, 252(1), 9-12. (Pubitemid 44920322)
80. Savettieri, G.; Cittadella, R.; Valentino, P.; Manna, I.; Andreoli, V.; La Russa, A.; La Porta, G.; Ruscica, F.; Ragonese, P.; Pirritano, D.; Bonavita, S.; Tedeschi, G.; Quattrone, A. Lack of association between estrogen receptor 1 gene polymorphisms and multiple sclerosis in southern Italy in humans. Neurosci. Lett., 2002, 327(2), 115-118. (Pubitemid 34722421)
81. Mattila, K.M.; Luomala, M.; Lehtimäki, T.; Laippala, P.; Koivula, T.; Elovaara, I. Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women. Neurology, 2001, 56(9), 1246-1247. (Pubitemid 32405732)
82. Kikuchi, S.; Fukazawa, T.; Niino, M.; Yabe, I.; Miyagishi, R.; Hamada, T.; Tashiro, K. Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLADRB1* 1501 and disease modulation. J. Neuroimmunol., 2002, 128(1-2), 77-81. (Pubitemid 34722366)
83. Niino, M.; Fukazawa, T.; Kikuchi, S.; Sasaki, H. Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications. Expert. Rev. Neurother., 2007, 7(9), 1175-1188. (Pubitemid 47451024)